Correction of Dystrophia Myotonica Type 1 Toxic RNA Transcripts Via Trans-Splicing

Dystrophia myotonica (DM1) a common form of muscular dystrophy is caused by a mutation within the DMPK gene.  In this study a type of gene therapy, SMaRT technology, was studied and examined as a potential therapy for DM1.